1-9 of 9
David Mutch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PR003: The combination of the glucagon like peptide-1 receptor agonist semaglutide and the progestin levonorgestrel is highly effective in preclinical studies of endometrial cancer

Kimberly K. Leslie, Andrea Hagemann, Kristina Thiel, Ian Hagemann, David Mutch, Eric Devor, Paige Malmrose
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (5_Supplement): PR003.
https://doi.org/10.1158/1557-3265.ENDO24-PR003
Published: 01 March 2024
View article titled, Abstract PR003: The combination of the glucagon like peptide-1 receptor agonist semaglutide and the progestin levonorgestrel is highly effective in preclinical studies of endometrial cancer
Journal Articles

A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia

Sandip P. Patel, Megan Othus, Young Kwang Chae, Michael J. Dennis, Sarah Gordon, David Mutch, Wolfram Samlowski, William R. “Rusty” Robinson, Elad Sharon, Christopher Ryan, Gabby Lopez, Melissa Plets, Charles Blanke, Razelle Kurzrock
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (1): 33–38.
https://doi.org/10.1158/1078-0432.CCR-23-2293
Published: 05 January 2024
View article titled, A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia
Open the PDF for A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia in another window
Includes: Supplementary data
Journal Articles

Abstract PO002: Inducing homologous recombination deficiency in uterine serous cancer (USC) using AVB-500, a receptor tyrosine kinase AXL inhibitor

Michael D. Toboni, Barbara Blachut, Elena Lomonosova, Dineo Khabele, Lindsay Kuroki, Andrea Hagemann, Carolyn McCourt, Premal Thaker, David Mutch, Matthew Powell, Katherine Fuh
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (3_Supplement): PO002.
https://doi.org/10.1158/1557-3265.ENDOMET20-PO002
Published: 01 February 2021
View article titled, Abstract PO002: Inducing homologous recombination deficiency in uterine serous cancer (USC) using AVB-500, a receptor tyrosine kinase AXL inhibitor
Journal Articles

Abstract PO047: AVB-500, a receptor tyrosine kinase AXL inhibitor, improves response to olaparib in uterine serous cancer

Michael D. Toboni, Mary Mullen, Jo'an Tankou, Hollie Noia, Alyssa Oplt, Daniel Wilke, Dineo Khabele, Lindsay Kuroki, Andrea Hagemann, Carolyn McCourt, Premal Thaker, David Mutch, Matthew Powell, Katherine Fuh
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (3_Supplement): PO047.
https://doi.org/10.1158/1557-3265.ENDOMET20-PO047
Published: 01 February 2021
View article titled, Abstract PO047: AVB-500, a receptor tyrosine kinase AXL inhibitor, improves response to olaparib in uterine serous cancer
Journal Articles

Abstract PR006: Correlation of immunohistochemistry with TP53 sequence and clinical outcomes in GOG-086P

Kristina W. Thiel, Eric J. Devor, Virginia Filiaci, Douglas A. Levine, Fanny Dao, Narciso Olvera, David Mutch, Carol Aghajanian, Kimberly K. Leslie
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (3_Supplement): PR006.
https://doi.org/10.1158/1557-3265.ENDOMET20-PR006
Published: 01 February 2021
View article titled, Abstract PR006: Correlation of immunohistochemistry with <em>TP53</em> sequence and clinical outcomes in GOG-086P
Journal Articles

Abstract PO045: Inhibition of GAS6/AXL improves efficacy of HER2 inhibitor trastuzumab in uterine serous cancer

Joan Tankou, Michael Toboni, Hollie Noia, Alyssa Oplt, Daniel Wilke, Dineo Khabele, Lindsay Kuroki, Andrea Hagemann, Carolyn McCourt, Premal Thaker, David Mutch, Matthew Powell, Katherine Fuh
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (3_Supplement): PO045.
https://doi.org/10.1158/1557-3265.ENDOMET20-PO045
Published: 01 February 2021
View article titled, Abstract PO045: Inhibition of GAS6/AXL improves efficacy of HER2 inhibitor trastuzumab in uterine serous cancer
Journal Articles

Abstract A13: Therapeutic AXL inhibition with AVB-S6-500 improves response to chemotherapy and induces a homologous recombination deficiency in ovarian cancer

Mary Margaret Mullen, Elena Lomonosova, Hollie Noia, Daniel Wilke, Alyssa Oplt, Lei Guo, Lindsay Kuroki, Andrea Hagemann, Carolyn McCourt, Premal Thaker, David Mutch, Matthew Powell, Katherine Fuh
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): A13.
https://doi.org/10.1158/1557-3265.OVCA19-A13
Published: 01 July 2020
View article titled, Abstract A13: Therapeutic AXL inhibition with AVB-S6-500 improves response to chemotherapy and induces a homologous recombination deficiency in ovarian cancer
Journal Articles

Abstract AP18: FUNCTIONAL GENOMIC SCREEN FOR ATTACHMENT AND INVASION IN METASTATIC OVARIAN CANCER

Katherine Fuh, Anne Gibson, Daniel Wilke, Maxene Ilagan, Andrea Hagemann, Carolyn McCourt, Premal Thaker, David Mutch, Matthew Powell, Gregory Longmore
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): AP18.
https://doi.org/10.1158/1557-3265.OVCASYMP16-AP18
Published: 31 May 2017
View article titled, Abstract AP18: FUNCTIONAL GENOMIC SCREEN FOR ATTACHMENT AND INVASION IN METASTATIC OVARIAN CANCER
Journal Articles

Evaluation of the Family History Collection Process and the Accuracy of Cancer Reporting among a Series of Women with Endometrial Cancer

Jennifer Ivanovich, Sheri Babb, Paul Goodfellow, David Mutch, Thomas Herzog, Janet Rader, Alison Whelan
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 1849–1856.
Published: 01 June 2002
View article titled, Evaluation of the Family History Collection Process and the Accuracy of Cancer Reporting among a Series of Women with Endometrial Cancer
Open the PDF for Evaluation of the Family History Collection Process and the Accuracy of Cancer Reporting among a Series of Women with Endometrial Cancer in another window